colony-stimulating factor


Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.
Related to colony-stimulating factor: Granulocyte colony-stimulating factor, macrophage colony stimulating factor, colony stimulating factor 2

colony-stimulating factor

[′käl·ə·nē ¦stim·yə‚lād·iŋ ‚fak·tər]
(immunology)
A group of lymphocytes that induce the maturation and proliferation of leukocyte, macrophage, and monocyte lines present in bone marrow.
Mentioned in ?
References in periodicals archive ?
Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma.
Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1 alpha, and granulocyte colony-stimulating factor.
Functional recovery of stroke rats induced by granulocyte colony-stimulating factor stimulated stem cells.
For example, higher cytotoxic plasma levels would lead to increased bone marrow suppression, increased febrile neutropenia, and a predisposition to AML / MDS, with increased predisposition also to use of granulocyte colony-stimulating factor," he explained.
Total quantity or scope: This framework agreement is for the supply of the Granulocyte Colony-Stimulating Factor (G-CSF) Filgrastim 300MCG and 480MCG presentations.
The strongest individual predictors for preterm birth were levels of maternal serum APP, alkaline phosphatase, and granulocyte colony-stimulating factor.
F-627 is a newer generation recombinant human granulocyte colony-stimulating factor (G-CSF) that helps the cancer patients to recover from chemotherapy induced neutropenia, a potentially life threatening condition.
Contract Award Notice: Framework Agreement is for the supply of Granulocyte colony-stimulating factor (G-CSF) to NHS Scotland
Before-hand, patients receive 7-10 days of injections with granulocyte colony-stimulating factor (G-CSF) to stimulate production and mobilization of stem cells in the bone marrow.
ESAs are second only to granulocyte colony-stimulating factor (G-CSF) therapies in anticipated market share in the G7 markets.
Contract award: Granulocyte colony-stimulating factor (G-CSF).
Topical granulocyte-macrophage colony-stimulating factor (GM-CSF) may have a desirable effect on macrophages.

Full browser ?